VIAP (VIA Pharmaceuticals) Debt-to-Equity : -0.76 (As of Dec. 2010)

VIA Pharmaceuticals Debt-to-Equity Chart

VIA Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
Debt-to-Equity		Get a 7-Day Free Trial					-1.36	-	-	-0.89	-0.76

VIA Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
Debt-to-Equity	Get a 7-Day Free Trial															-0.89	-0.81	-0.75	-0.75	-0.76

Competitive Comparison of VIA Pharmaceuticals's Debt-to-Equity

For the Biotechnology subindustry, VIA Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIA Pharmaceuticals's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIA Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where VIA Pharmaceuticals's Debt-to-Equity falls into.

VIA Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

VIA Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2010 is calculated as

VIA Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Dec. 2010 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VIA Pharmaceuticals  (GREY:VIAP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

VIA Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of VIA Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

VIA Pharmaceuticals Business Description